After Helsinki: unresolved issues in international research
- PMID: 12166444
- DOI: 10.1353/ken.2001.0005
After Helsinki: unresolved issues in international research
Abstract
Following a long process of revision, a new version of the Declaration of Helsinki was approved by the World Medical Association in 2000. Two provisions of the Declaration address ongoing international controversies regarding research sponsored by industrialized countries and conducted in developing countries. Despite the issuance of the final version of the Declaration, opponents remain locked in debate. Moreover, the Declaration remained silent on other prominent controversies concerning international research. An analysis of these current controversies reveals reasons why they are not likely to be readily resolved, despite apparent agreement by opponents on overarching ethical principles.
Similar articles
-
Ethical considerations in industry-sponsored multiregional clinical trials.Pharm Stat. 2010 Jul-Sep;9(3):230-41. doi: 10.1002/pst.458. Pharm Stat. 2010. PMID: 20824884
-
Ethical issues in the design and conduct of clinical trials in developing countries.N Engl J Med. 2001 Jul 12;345(2):139-42. doi: 10.1056/NEJM200107123450212. N Engl J Med. 2001. PMID: 11450665 No abstract available.
-
Helsinki Declaration revisions.Issues Med Ethics. 2001 Jan-Mar;9(1):29. Issues Med Ethics. 2001. PMID: 16334459 No abstract available.
-
What are the effects of the fifth revision of the Declaration of Helsinki?BMJ. 2001 Dec 15;323(7326):1417-23. doi: 10.1136/bmj.323.7326.1417. BMJ. 2001. PMID: 11744569 Free PMC article. Review. No abstract available.
-
International research: ethical imperialism or ethical pluralism?Account Res. 1999;7(1):59-83. doi: 10.1080/08989629908573942. Account Res. 1999. PMID: 11657563 Review. No abstract available.
Cited by
-
Placebo orthodoxy and the double standard of care in multinational clinical research.Theor Med Bioeth. 2015 Feb;36(1):7-23. doi: 10.1007/s11017-015-9317-9. Theor Med Bioeth. 2015. PMID: 25663050
-
Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders' views in Kenya.Philos Ethics Humanit Med. 2012 Jan 17;7:7. doi: 10.1186/1747-5341-7-7. Philos Ethics Humanit Med. 2012. PMID: 22251457 Free PMC article.
-
Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.BMC Med Ethics. 2014 Jun 30;15:51. doi: 10.1186/1472-6939-15-51. BMC Med Ethics. 2014. PMID: 24981027 Free PMC article.
-
Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.HIV Clin Trials. 2009 Jan-Feb;10(1):13-24. doi: 10.1310/hct1001-13. HIV Clin Trials. 2009. PMID: 19362992 Free PMC article.
-
For love and money: the need to rethink benefits in HIV cure studies.J Med Ethics. 2017 Feb;43(2):96-99. doi: 10.1136/medethics-2015-103119. Epub 2016 May 18. J Med Ethics. 2017. PMID: 27193021 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical